Delray Beach, FL – Feb 5, 2020 – TMS of the Palm Beaches – a healthcare provider that specializes in transcranial magnetic stimulation (TMS) – made an important announcement concerning its recent partnership with Neuronetics, Inc. According to TMS of the Palm Beaches, this historic partnership will give depression patients in Delray Beach increased access to revolutionary depression treatment. TMS of the Palm Beaches shared that, as part of the partnership, the company will use Neuronetics’ NeuroStar Advanced Therapy System as its preferred TMS device.
According to TMS of the Palm Beaches, NeuroStar TMS has proven to be effective. In a recent independent study by the National Institute of Mental Health (NIMH), patients who received TMS treatment using a clinical trial version of the NeuroStar TMS system were 4.2 times more likely to achieve remission than patients receiving sham treatment. TMS of the Palm Beaches described this non-invasive form of neuromodulation as the number one TMS choice for doctors in the field. TMS of the Palm Beaches also said that the NeuroStar Advanced Therapy System is covered by most insurance plans, including Medicare. TMS of the Palm Beaches indicated that it is excited to use this cutting-edge depression management system at its Delray Beach Depression Treatment Center.
TMS of the Palm Beaches provided useful information about its new partner, Neuronetics. TMS of the Palm Beaches described Neuronetics as a commercial-stage medical technology company that focuses on the design, development, and marketing of products that help treat patients who suffer from psychiatric disorders. TMS of the Palm Beaches also stated that the NeuroStar Advanced Therapy System was Neuronetics’ first commercial product.
According to TMS of the Palm Beaches, this product provides non-invasive and non-systemic office-based treatment for patients suffering from depression. This treatment uses transcranial magnetic stimulation (TMS) to create a pulsed, MRI-strength magnetic field. This magnetic field induces electrical currents designed to stimulate specific areas of the brain that are associated with mood. TMS of the Palm Beaches pointed out that this system has been approved by the United States Food and Drug Administration (FDA) for the treatment of Major Depressive Disorder in adult patients who have not shown significant improvement from prior antidepressant medication in the current episode.
For more information, visit: https://www.youtube.com/watch?v=wmUKW-0z3FM&feature=emb_title
Company Name: TMS of the Palm Beaches
Contact Person: Hasna Jabr
Email: Send Email
Address:4205 W. Atlantic Ave. Ste C301
City: Delray Beach
Country: United States